Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#87 / 87 Total
TSVT - 2seventy bio Inc - Stock Price Chart
TickerTSVT [NASD, RUT]
Company2seventy bio Inc
CountryUSA
IndustryBiotechnology
Market Cap234.43MEPS (ttm)-4.34
P/E-EPS this Y44.01%
Forward P/E-EPS next Y64.39%
PEG-EPS past 5Y-
P/S3.29EPS next 5Y-
P/B1.13EPS Q/Q6.48%
Dividend-Sales Q/Q-70.12%
Insider Own7.16%Inst Own91.06%
Insider Trans22.74%Inst Trans-1.51%
Short Float14.58%EarningsMay 08/b
Analyst Recom2.14Target Price11.20
Avg Volume1.06M52W Range1.53 - 12.69
May-12-24 03:24PM 5 Penny Stocks with Insider Buying in 2024 (Insider Monkey)
May-08-24 11:57AM TSVT Stock Earnings: 2seventy bio Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace) -9.68%
08:15AM 2seventy bio, Inc. (TSVT) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:00AM 2seventy bio Reports First Quarter Financial Results and Recent Operational Progress (Business Wire)
May-03-24 07:00AM 2seventy bio to Report First Quarter 2024 Financial Results on May 8, 2024 (Business Wire)
Apr-24-24 10:01AM 2seventy bio, Inc. (TSVT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks) -7.78%
Apr-17-24 11:02AM 2seventy bio (TSVT) Rises More Than 50% in 3 Months: Here's Why (Zacks)
Apr-05-24 09:05AM U.S. FDA Approves Bristol Myers Squibb and 2seventy bios Abecma for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma After Two Prior Lines of Therapy (Business Wire)
Apr-01-24 07:30AM 2seventy bio Announces Completion of Oncology and Autoimmune Pipeline Divestiture to Regeneron (Business Wire) +8.22%
Mar-20-24 05:04PM 2seventy bio Announces Appointments of Eli Casdin and Charles Newton to Board of Directors (Business Wire)
2seventy Bio, Inc. operates as cell and gene therapy company. It concentrates on the research, development, and commercialization of transformative treatments for cancer. The company was founded on April 26, 2021 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Snow JessicaSee RemarksMay 03 '24Sale4.91157456,271May 16 06:40 PM
Casdin Capital, LLCDirectorMar 26 '24Buy5.1040,000203,9922,000,000Mar 28 08:29 PM
Casdin Capital, LLCDirectorMar 25 '24Buy5.07330,0001,673,9911,960,000Mar 25 09:44 PM
Casdin Capital, LLCDirectorMar 22 '24Buy5.12147,377754,0691,630,000Mar 25 09:44 PM
Casdin Capital, LLCDirectorMar 21 '24Buy4.90300,0001,470,9901,482,623Mar 25 09:44 PM
123456789
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.